COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

Metformin boosts survival for female COVID-19 patients with obesity, type 2 diabetes

These trends were not observed among male COVID-19 patients.

Is there honor among thieves who would hold hospitals hostage if not for COVID?

A trend has emerged of evidently softhearted ransomware gangs swearing off hospitals during the COVID crisis.

3 online COVID trackers to bookmark now and check whenever

This week NPR has posted three interactive infographics that health execs may find especially valuable as COVID-19 surges in spots across the U.S. and around the world.

Statins, ACE inhibitors lower risk of death from COVID-19—hydroxychloroquine increases that risk

The study, published in JAMA Network Open, included data from more than 64,000 COVID-19 patients.

Cardiologist accuses medical industry of ‘therapeutic nihilism’ on Fox News as host pushes COVID-19 conspiracy

Cardiologist Peter A. McCullough, MD, appeared on Fox News to discuss the medical community’s “therapeutic nihilism” when it comes to potential COVID-19 treatments such as hydroxychloroquine.

Thumbnail

Fewer severe heart attack patients underwent PCI during the early months of the pandemic

The study, published in the American Journal of Cardiology, tracked data from 51 different hospitals in the state of New York. 

COVID-19 coronavirus burnout depression pandemic

COVID-19 passes heart disease as No. 1 cause of death in US

An estimated 15% of the country has now had COVID-19. 

Hydroxychloroquine unable to limit spread, or severity, of COVID-19 after exposure

There are no benefits to treating patients with hydroxychloroquine after they have already been exposed to COVID-19, according to a new study published in the New England Journal of Medicine.